U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H15ClN4O2
Molecular Weight 354.79
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OLUTASIDENIB

SMILES

C[C@H](NC1=CC=C(C#N)N(C)C1=O)C2=CC3=C(NC2=O)C=CC(Cl)=C3

InChI

InChIKey=NEQYWYXGTJDAKR-JTQLQIEISA-N
InChI=1S/C18H15ClN4O2/c1-10(21-16-6-4-13(9-20)23(2)18(16)25)14-8-11-7-12(19)3-5-15(11)22-17(14)24/h3-8,10,21H,1-2H3,(H,22,24)/t10-/m0/s1

HIDE SMILES / InChI
Molecular Formula C18H16ClN
Molecular Weight 281.779
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

2022
358
Substance Class Chemical
Created
by admin
on Sat Dec 16 13:59:34 UTC 2023
Edited
by admin
on Sat Dec 16 13:59:34 UTC 2023
Record UNII
0T4IMT8S5Z
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OLUTASIDENIB
INN   USAN  
Official Name English
olutasidenib [INN]
Common Name English
5-{[(1S)-1-(6-Chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl]amino}-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
Systematic Name English
(S)-5-((1-(6-CHLORO-2-OXO-1,2-DIHYDROQUINOLIN-3-YL)ETHYL)AMINO)-1-METHYL-6-OXO-1,6-DIHYDROPYRIDINE-2-CARBONITRILE
Systematic Name English
REZLIDHIA
Brand Name English
FT-2102
Code English
Olutasidenib [WHO-DD]
Common Name English
2-PYRIDINECARBONITRILE, 5-(((1S)-1-(6-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINYL)ETHYL)AMINO)-1,6-DIHYDRO-1-METHYL-6-OXO-
Systematic Name English
OLUTASIDENIB [USAN]
Common Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/19/2159
Created by admin on Sat Dec 16 13:59:34 UTC 2023 , Edited by admin on Sat Dec 16 13:59:34 UTC 2023
FDA ORPHAN DRUG 565716
Created by admin on Sat Dec 16 13:59:34 UTC 2023 , Edited by admin on Sat Dec 16 13:59:34 UTC 2023
Code System Code Type Description
RXCUI
2623641
Created by admin on Sat Dec 16 13:59:34 UTC 2023 , Edited by admin on Sat Dec 16 13:59:34 UTC 2023
PRIMARY
INN
11036
Created by admin on Sat Dec 16 13:59:34 UTC 2023 , Edited by admin on Sat Dec 16 13:59:34 UTC 2023
PRIMARY
USAN
FG-59
Created by admin on Sat Dec 16 13:59:34 UTC 2023 , Edited by admin on Sat Dec 16 13:59:34 UTC 2023
PRIMARY
SMS_ID
100000181628
Created by admin on Sat Dec 16 13:59:34 UTC 2023 , Edited by admin on Sat Dec 16 13:59:34 UTC 2023
PRIMARY
PUBCHEM
118955396
Created by admin on Sat Dec 16 13:59:34 UTC 2023 , Edited by admin on Sat Dec 16 13:59:34 UTC 2023
PRIMARY
NCI_THESAURUS
C129687
Created by admin on Sat Dec 16 13:59:34 UTC 2023 , Edited by admin on Sat Dec 16 13:59:34 UTC 2023
PRIMARY
EVMPD
SUB195399
Created by admin on Sat Dec 16 13:59:34 UTC 2023 , Edited by admin on Sat Dec 16 13:59:34 UTC 2023
PRIMARY
FDA UNII
0T4IMT8S5Z
Created by admin on Sat Dec 16 13:59:34 UTC 2023 , Edited by admin on Sat Dec 16 13:59:34 UTC 2023
PRIMARY
DAILYMED
0T4IMT8S5Z
Created by admin on Sat Dec 16 13:59:34 UTC 2023 , Edited by admin on Sat Dec 16 13:59:34 UTC 2023
PRIMARY
CAS
1887014-12-1
Created by admin on Sat Dec 16 13:59:34 UTC 2023 , Edited by admin on Sat Dec 16 13:59:34 UTC 2023
PRIMARY
Related Record Type Details
ISOCITRATE DEHYDROGENASE (NADP) CYTOPLASMIC
TARGET->WEAK INHIBITOR
IC50
ISOCITRATE DEHYDROGENASE (NADP) CYTOPLASMIC R132C
TARGET -> INHIBITOR
IC50
ISOCITRATE DEHYDROGENASE (NADP) CYTOPLASMIC R132H
TARGET -> INHIBITOR
IC50
Related Record Type Details
Structure of OLUTASIDENIB
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966